Infections in hematology / Georg Maschmeyer, Kenneth V.I. Rolston, editors.
Infections are among the most frequent complications in patients with hematological malignancies and in those undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation. A profound knowledge on the epidemiology, diagnostic approaches, treatment modalities and prophylact...
Saved in:
| Online Access: |
Full Text (via Springer) |
|---|---|
| Other Authors: | , |
| Format: | eBook |
| Language: | English |
| Published: |
Heidelberg :
Springer,
[2014]
|
| Subjects: |
Table of Contents:
- Introduction; Contents; Part I: Epidemiology: Infections in Patients with Hematologic Malignancies; 1: Infections in Patients with Acute Leukemia; 1.1 Introduction; 1.2 Nature of Febrile Episodes; 1.3 Clinically Documented Infections; 1.4 Microbiologically Documented Infections; 1.5 Sites of Infection; 1.6 Spectrum of Bacterial Infection; 1.6.1 Gram-Positive Organisms; 1.6.2 Gram-Negative Bacilli; 1.7 Fungal Infections; 1.7.1 Viral Infections; 1.8 Summary; References; 2: Infections in Patients with Malignant Lymphomas; 2.1 Introduction; 2.2 Neutropenia; 2.3 Humoral Immunity.
- 2.4 Cell-Mediated Immunity2.5 Bacterial Infections; 2.6 Mycobacterial Infections; 2.7 Fungal Infections; 2.8 Parasitic Infections; 2.9 Central Nervous System Infections; 2.10 Pulmonary Infections; References; 3: Consequences from Specific Treatment Modalities; 3.1 Purine Analogs; 3.2 Monoclonal Antibodies; 3.2.1 Anti-CD20 Antibodies; 3.2.2 Alemtuzumab (Anti-CD52 Antibody); 3.2.3 Antibodies to Tumor Necrosis Factor Alpha (TNF-Alpha); References; 4: Infections After High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation; 4.1 Introduction.
- 4.2 Risk for and Epidemiology of Infection4.2.1 Pre-Engraftment Period; 4.2.2 Post-engraftment Period; 4.3 Summary; References; 5: Microbiological Background; 5.1 Introduction; 5.2 Bacterial Infections; 5.2.1 Gram-Positive Bacteria and Their Antimicrobial Susceptibility; 5.2.1.1 Coagulase-Negative Staphylococci (CNS); 5.2.1.2 Staphylococcus aureus; 5.2.1.3 Enterococci; 5.2.1.4 Viridans Streptococci; 5.2.1.5 Streptococcus pneumoniae; 5.2.2 Gram-Negative Bacteria and Their Antimicrobial Susceptibility; 5.2.2.1 Enteric Gram-Negatives; 5.2.2.2 Pseudomonas aeruginosa.
- 5.2.2.3 Other Non-fermentative Bacteria5.2.3 Anaerobic Bacteria; 5.2.4 Unusual Bacteria; 5.3 Invasive Fungal Infections; 5.3.1 Candida spp.; 5.3.2 Other Opportunistic Yeast-Like Fungi; 5.3.3 Aspergillus spp.; 5.3.4 Zygomycetes; 5.3.5 Other Rare Molds; References; Part II: Diagnosis; 6: The Diagnostic Approach to the Febrile Neutropenic Patient: Clinical Considerations; 6.1 Introduction; 6.2 Neutropenia and Timing of Neutropenic Fevers; 6.3 Risks and Predictors for Neutropenic Fever; 6.4 Classification of Neutropenic Fever Syndromes; 6.5 Is the Patient Febrile? Measurement of Body Temperature.
- 6.6 Risk for Serious Medical Complications Associated with the Neutropenic Fever Syndrome6.7 Presentation to the Outpatient Clinic or to the Emergency Department; References; 7: Diagnostic Radiology in Hematological Patients with Febrile Neutropenia; 7.1 Early Detection of Pneumonia; 7.1.1 Conventional Chest Radiograph; 7.1.2 CT Technique and Terminology; 7.1.3 CT; 7.1.4 Magnetic-Resonance Tomography (MRI); 7.1.5 Recommendation for Clinical Practice; 7.2 Monitoring of Lung Infiltrates; 7.3 Characterization of Pneumonia; 7.3.1 Bacterial Pneumonia; 7.3.2 Fungal Pneumonia.